• Overview
  Quotes Prices Key Stats News Press Releases Sentiment
• Charts
  Chart Technicals
• Company
  Splits Dividends Recommendations Price Target Insider Trades Holders Peers Filings Notes due Fail to deliver ESG Score Executive Compensation Profile
• Earnings
  Price Reaction Earnings Estimates Trends Call Transcripts
• Financials
  Fundamentals DCF Beta
• Options
  Option Chain Option Strategies Put/Call Ratios
• Analysis
  Up/Down Intra-day Events Performance Recovery Returns Price Distribution Unusual Volume Best Days Data Correlations Seasonality Volatility Trader Stats

Summary

News

05/09 08:00 EST - globenewswire.com
Stryker declares a $0.80 per share quarterly dividend
Portage, Michigan, May 09, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.80 per share payable July 31, 2024 to shareholders of record at the close of business on June 28, 2024, representing an increase of 6.7% versus the prior year and unchanged from the previous quarter.

05/07 02:10 EST - businesswire.com
First Surgeries Using Stryker's Infinity With Adaptis and Everlast Successfully Completed in Europe
AMSTERDAM--(BUSINESS WIRE)--Stryker announced the completion of the first European surgeries using the Infinity Total Ankle System with Adaptis and Everlast technology.

05/01 10:16 EST - zacks.com
Stryker's (SYK) Q1 Earnings Beat Estimates, Guidance Raised
Stryker's (SYK) first-quarter earnings reflect strong performance across its segments and geographies. Operating and gross margins increase, with earnings and revenues beating their respective estimates.

04/30 20:30 EST - seekingalpha.com
Stryker Corporation (SYK) Q1 2024 Earnings Call Transcript
Start Time: 16:30 January 1, 0000 5:28 PM ET Stryker Corporation (NYSE:SYK ) Q1 2024 Earnings Conference Call April 30, 2024, 16:30 PM ET Company Participants Kevin Lobo - Chair and CEO Glenn Boehnlein - VP and CFO Jason Beach - VP, Finance and IR Conference Call Participants Robert Marcus - JPMorgan Lawrence Biegelsen - Wells Fargo Securities Ryan Zimmerman - BTIG Joanne Wuensch - Citibank Pito Chickering - Deutsche Bank Shagun Singh Chadha - RBC Capital Vijay Kumar - Evercore Travis Steed - Bank of America Matthew O'Brien - Piper Sandler Matt Miksic - Barclays Danielle Antalffy - UBS Matt Taylor - Jefferies Caitlin Cronin - Canaccord Sam Brodovsky - Truist Joshua Jennings - Cowen Andrew Ranieri - Morgan Stanley Operator Welcome to the First Quarter 2024 Stryker Earnings Call. My name is Christine, and I'm your operator for today's call.

04/30 19:33 EST - reuters.com
Stryker lifts 2024 profit forecast on strong demand for medical devices, implants
Stryker Corp lifted its full-year profit forecast on Tuesday, owing to resilient demand for the company's medical devices and implants.

04/30 19:01 EST - zacks.com
Here's What Key Metrics Tell Us About Stryker (SYK) Q1 Earnings
The headline numbers for Stryker (SYK) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

04/30 18:26 EST - zacks.com
Stryker (SYK) Beats Q1 Earnings and Revenue Estimates
Stryker (SYK) came out with quarterly earnings of $2.50 per share, beating the Zacks Consensus Estimate of $2.35 per share. This compares to earnings of $2.14 per share a year ago.

04/30 16:05 EST - globenewswire.com
Stryker reports first quarter 2024 operating results
Portage, Michigan, April 30, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the first quarter of 2024:

04/25 10:20 EST - zacks.com
Seeking Clues to Stryker (SYK) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics
Evaluate the expected performance of Stryker (SYK) for the quarter ended March 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

04/24 13:46 EST - zacks.com
SYK vs ZBH: Which Stock Looks More Promising Ahead of Q1 Earnings?
SYK and ZBH are expected to have witnessed strong procedural volume growth across the global market in the first quarter.

04/24 07:26 EST - zacks.com
Ongoing Procedural Growth May Aid Stryker's (SYK) Q1 Earnings
Stryker's (SYK) first-quarter 2024 results are expected to reflect strong segmental performance. However, rising costs are likely to have continued to hurt margins.

04/23 13:38 EST - investorplace.com
Medical AI Could Be Your Ticket to Riches: 3 Stocks to Buy
While artificial intelligence may be useful for a variety of purposes – including asking silly questions we're afraid to pose in real life – the ultimate end game for digital intelligence could be to advance the human condition, which brings us to medical AI stocks. When conducted in a controlled environment, AI can help accelerate productivity.

04/23 11:07 EST - zacks.com
Stryker (SYK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Stryker (SYK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

04/18 09:35 EST - investorplace.com
3 Robotics Stocks to Turn $1000 into $1 Million: April 2024
Robotics and related technologies, such as workflow automation products, cloud services, and generative AI technology, have captivated the investing community. They have assisted in leading the overall market higher over this past year especially.

04/04 09:05 EST - businesswire.com
Spineology® Appoints new Member to Leadership Team; Spine Veteran Emory Rooney joins as Executive Vice President of Sales
ST. PAUL, Minn.--(BUSINESS WIRE)--Spineology Inc. ("Spineology" or the "Company"), the leader in ultra-minimally invasive spine surgery, announced today the addition of Emory Rooney as Executive Vice President, Sales. In this role, Rooney will lead U.S. market growth and sales efforts. Rooney comes to Spineology with extensive spine sales experience, having served in Medical Device fields related to spinal implants and navigation for nearly 20 years. “The addition of Emory adds even further con.

04/02 09:37 EST - zacks.com
5 Medical Product Stocks to Buy Amid Industry Challenges
Despite the ongoing macro headwinds, recovering demand for medical procedures and cost-cutting initiatives should support the Zacks Medical-Products industry. SYK, RMD, ZBH, PODD and LNTH are well-poised to gain from the favorable factors.

04/01 16:05 EST - globenewswire.com
Stryker to announce financial results for its first quarter of fiscal year 2024
Portage, Michigan, April 01, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will report financial results for first quarter of fiscal year 2024 on Tuesday, April 30, 2024.  A press release will be issued at approximately 4:05pm ET and available at Stryker - Press Releases that day. The press release will include summary financial information for the company's first quarter of fiscal year 2024, that ended March 31, 2024.

03/29 10:46 EST - zacks.com
Is Stryker (SYK) Stock Outpacing Its Medical Peers This Year?
Here is how Stryker (SYK) and Athira Pharma, Inc. (ATHA) have performed compared to their sector so far this year.

03/27 11:56 EST - zacks.com
Stryker's (SYK) Latest Launch to Streamline Procedural Workflows
Stryker's (SYK) latest addition to its Gamma legacy is expected to streamline workflows and enhance usability.

03/26 16:05 EST - globenewswire.com
Stryker announces Annual Meeting of Shareholders
Portage, Michigan, March 26, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced its 2024 Annual Meeting of Shareholders is scheduled as follows: